Activating KCNJ11 mutations are associated with a number of clinical features ranging from isolated diabetes to more severe phenotypes such as developmental delay-epilepsy-neonatal diabetes syndrome (Gloyn et al., 2006). This evidence concerns the gene KCNJ11 and diabetes mellitus.